Literature DB >> 27436366

Perioperative outcomes of esophageal cancer surgery in a mid-volume institution in the era of centralization.

Silvio Däster1, Savas D Soysal2, Luca Koechlin2, Lea Stoll2, Ralph Peterli2, Markus von Flüe2, Christoph Ackermann2.   

Abstract

BACKGROUND: Centralization of esophageal cancer surgery to high-volume institutions has been shown to improve perioperative outcomes in several studies. However, there is an ongoing debate, whether defined minimal annual hospital volumes for esophagectomies are required for quality assurance. The aim of the study was to assess perioperative outcomes of esophagectomies in a single institution in Switzerland.
METHODS: Data from a database of esophagectomies performed between 2004 and 2013 was analyzed. Perioperative morbidity of esophagectomies due to cancer was assessed according to the Clavien-Dindo classification. Postoperative mortality was defined as death from any cause within the same hospital stay.
RESULTS: A total of 143 operations (125 transthoracic esophagectomies, 18 extended transhiatal gastrectomies) were performed in the surveyed 10-year period. Two surgeons performed 91 % of all procedures. Postoperative morbidity was 43.4 %. Complications with a Clavien-Dindo score of III/IV (requiring surgical, endoscopic, or radiological intervention) occurred in 19 cases (13.4 %). The overall anastomotic leak rate was 3.5 %. Pulmonary complications were the most frequent postoperative problems involving 21 % of patients. In-hospital mortality was 0.7 %. Mean length of hospital stay was 17 days in patients with no complications and 22 days if there were any complications (p < 0.001).
CONCLUSION: Esophageal cancer surgery is complex and has a significant risk of morbidity. The most common postoperative problems are pulmonary complications, usually responding well to non-invasive treatment. Appropriate patient selection and preparation, high surgeon volume, and a comprehensive multidisciplinary care pathway can provide a low perioperative mortality rate in a mid-volume institution.

Entities:  

Keywords:  Esophageal cancer; Esophagectomy; Hospital volume; Perioperative outcomes

Mesh:

Year:  2016        PMID: 27436366     DOI: 10.1007/s00423-016-1477-1

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  52 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Carcinoma of the OEsophagus. Radical Resection with OEsophago-gastrostomy for a Midthoracic Growth by a Right Transpleural Approach.

Authors:  I Lewis
Journal:  Proc R Soc Med       Date:  1945-07

Review 3.  Outcomes in the management of esophageal cancer.

Authors:  Subroto Paul; Nasser Altorki
Journal:  J Surg Oncol       Date:  2014-08-21       Impact factor: 3.454

4.  Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial.

Authors:  Surya S A Y Biere; Mark I van Berge Henegouwen; Kirsten W Maas; Luigi Bonavina; Camiel Rosman; Josep Roig Garcia; Suzanne S Gisbertz; Jean H G Klinkenbijl; Markus W Hollmann; Elly S M de Lange; H Jaap Bonjer; Donald L van der Peet; Miguel A Cuesta
Journal:  Lancet       Date:  2012-05-01       Impact factor: 79.321

5.  Case volume as a predictor of inpatient mortality after esophagectomy.

Authors:  Michael Rodgers; Blair A Jobe; Robert W O'Rourke; Brett Sheppard; Brian Diggs; John G Hunter
Journal:  Arch Surg       Date:  2007-09

6.  Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?

Authors:  B Mungo; D Molena; M Stem; S C Yang; R J Battafarano; M V Brock; A O Lidor
Journal:  Dis Esophagus       Date:  2014-07-24       Impact factor: 3.429

Review 7.  Reducing hospital morbidity and mortality following esophagectomy.

Authors:  B Zane Atkins; Ashish S Shah; Kelley A Hutcheson; Jennifer H Mangum; Theodore N Pappas; David H Harpole; Thomas A D'Amico
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

8.  Surgery of gastric cancer and esophageal cancer: Does age matter?

Authors:  Henrik Nienhueser; Romy Kunzmann; Leila Sisic; Susanne Blank; Moritz J Strowitzk; Thomas Bruckner; Dirk Jäger; Wilko Weichert; Alexis Ulrich; Markus W Büchler; Katja Ott; Thomas Schmidt
Journal:  J Surg Oncol       Date:  2015-08-25       Impact factor: 3.454

9.  Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis.

Authors:  Kamal Nagpal; Kamran Ahmed; Amit Vats; Danny Yakoub; David James; Hutan Ashrafian; Ara Darzi; Krishna Moorthy; Thanos Athanasiou
Journal:  Surg Endosc       Date:  2010-01-28       Impact factor: 4.584

Review 10.  Reporting of short-term clinical outcomes after esophagectomy: a systematic review.

Authors:  Natalie S Blencowe; Sean Strong; Angus G K McNair; Sara T Brookes; Tom Crosby; S Michael Griffin; Jane M Blazeby
Journal:  Ann Surg       Date:  2012-04       Impact factor: 12.969

View more
  3 in total

Review 1.  Regionalization of esophagectomy: where are we now?

Authors:  James M Clark; Daniel J Boffa; Robert A Meguid; Lisa M Brown; David T Cooke
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

2.  Continuously sutured versus linear-stapled anastomosis in robot-assisted hybrid Ivor Lewis esophageal surgery following neoadjuvant chemoradiotherapy: a single-center cohort study.

Authors:  Fiorenzo V Angehrn; Kerstin J Neuschütz; Daniel C Steinemann; Martin Bolli; Lana Fourie; Pauline Becker; Markus von Flüe
Journal:  Surg Endosc       Date:  2022-07-19       Impact factor: 3.453

3.  From open Ivor Lewis esophagectomy to a hybrid robotic-assisted thoracoscopic approach: a single-center experience over two decades.

Authors:  Fiorenzo V Angehrn; Kerstin J Neuschütz; Lana Fourie; Alexander Wilhelm; Silvio Däster; Christoph Ackermann; Markus von Flüe; Daniel C Steinemann; Martin Bolli
Journal:  Langenbecks Arch Surg       Date:  2022-03-24       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.